• SPX
  • 5969.34
  • 0.35 %
  • 20.6299
  • DJI
  • 44296.51
  • 0.97 %
  • 426.1602
  • N225
  • 38283.85
  • 0.68 %
  • 257.6797
  • FTSE
  • 8262.08
  • 1.38 %
  • 112.8101
  • IXIC
  • 19003.65
  • 0.16 %
  • 31.2305
Asensus Surgical, Inc. (ASXC) Stock Price, News & Analysis

Asensus Surgical, Inc. (ASXC) Stock Price, News & Analysis

Currency in USD Disclaimer

NA

NA

NA

Day's range
$0.35
Day's range
$0.35
50-day range
$0.169
Day's range
$0.3495
  • Country: US
  • ISIN: US04367G1031
52 wk range
$0.17
Day's range
$0.4
Notice: This company has been marked as potentially delisted and may not be actively trading.


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -41.32
  • Piotroski Score 3.00
  • Grade Neutral
  • Symbol (ASXC)
  • Company Asensus Surgical, Inc.
  • Price $0.35
  • Changes Percentage (0.64%)
  • Change -$0
  • Day Low $0.35
  • Day High $0.35
  • Year High $0.40

Asensus Surgical, Inc., a medical device company, engages in the research, development, and sale of medical device robotics to enhance minimally invasive surgery (MIS) in the United States, Europe, and Asia. It digitizes the interface between the surgeon and the patient to pioneer a new era of Performance-Guided surgery by unlocking clinical intelligence for surgeons to enable consistently superior outcomes and a new standard of surgery. The company's products include Senhance Surgical system, a multi-port robotic surgery system that allows up to four arms to control robotic instruments and a camera for laparoscopic procedures. Its products also comprise instruments and other products, including 3mm diameter instruments, 3mm and 5mm hooks, and articulating instruments; and Senhance ultrasonic system, an advanced energy device to deliver controlled energy to ligate and divide tissue. The company was formerly known as TransEnterix, Inc. and changed its name to Asensus Surgical, Inc. in February 2021. Asensus Surgical, Inc. was founded in 2006 and is headquartered in Durham, North Carolina.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 11/12/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $1.50
  • High Stock Price Target $1.50
  • Low Stock Price Target $1.50
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$0.30
  • Trailing P/E Ratio -1.11
  • Forward P/E Ratio -1.11
  • P/E Growth -1.11
  • Net Income $-78,433,000

Income Statement

Quarterly

Annual

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Asensus Surgical, Inc. Frequently Asked Questions

  • What is the Asensus Surgical, Inc. stock price today?

    Today's price of Asensus Surgical, Inc. is $0.35 — it has decreased by 0.64% in the past 24 hours. Watch Asensus Surgical, Inc. stock price performance more closely on the chart.

  • Does Asensus Surgical, Inc. release reports?

    Yes, you can track Asensus Surgical, Inc.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Asensus Surgical, Inc. stock forecast?

    Watch the Asensus Surgical, Inc. chart and read a more detailed Asensus Surgical, Inc. stock forecast to see what analysts suggest you do with its shares.

  • What is Asensus Surgical, Inc. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on AMEX, exchange stock trades by Asensus Surgical, Inc. stock ticker.

  • How to buy Asensus Surgical, Inc. stocks?

    Like other stocks, ASXC shares are sold on stock exchanges such as AMEX. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Asensus Surgical, Inc.'s EBITDA?

    Asensus Surgical, Inc. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Asensus Surgical, Inc.’s financial statements.

  • What is the Asensus Surgical, Inc.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -9.1445726944, which equates to approximately -914.46%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Asensus Surgical, Inc. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Asensus Surgical, Inc.'s financials relevant news, and technical analysis. Asensus Surgical, Inc.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Asensus Surgical, Inc. stock currently indicates a “sell” signal. For more insights, review Asensus Surgical, Inc.’s technical analysis.

  • A revenue figure for Asensus Surgical, Inc. for its last quarter?

    Asensus Surgical, Inc. published it's last quarterly revenues at $2.21 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.